Our Science & Pipeline

Pipeline

We are building a deep pipeline and plan to run simultaneous Phase 2 clinical trials as we seek to address multiple synaptopathies. We plan to start with Alzheimer’s disease in a Phase 1b study and then expand into other indications.

Program Pipeline